Literature DB >> 27913514

Understanding red blood cell alloimmunization triggers.

Jeanne E Hendrickson1,2, Christopher A Tormey1,3.   

Abstract

Blood group alloimmunization is "triggered" when a person lacking a particular antigen is exposed to this antigen during transfusion or pregnancy. Although exposure to an antigen is necessary for alloimmunization to occur, it is not alone sufficient. Blood group antigens are diverse in structure, function, and immunogenicity. In addition to red blood cells (RBCs), a recipient of an RBC transfusion is exposed to donor plasma, white blood cells, and platelets; the potential contribution of these elements to RBC alloimmunization remains unclear. Much attention in recent years has been placed on recipient factors that influence RBC alloantibody responses. Danger signals, identified in murine and human studies alike as being risk factors for alloimmunization, may be quite diverse in nature. In addition to exogenous or condition-associated inflammation, autoimmunity is also a risk factor for alloantibody formation. Triggers for alloimmunization in pregnancy are not well-understood beyond the presence of a fetal/maternal bleed. Studies using animal models of pregnancy-induced RBC alloimmunization may provide insight in this regard. A better understanding of alloimmunization triggers and signatures of "responders" and "nonresponders" is needed for prevention strategies to be optimized. A common goal of such strategies is increased transfusion safety and improved pregnancy outcomes.
© 2016 by The American Society of Hematology. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27913514      PMCID: PMC6142457          DOI: 10.1182/asheducation-2016.1.446

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  41 in total

1.  Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs.

Authors:  Nicole H Smith; Eldad A Hod; Steven L Spitalnik; James C Zimring; Jeanne E Hendrickson
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

2.  Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials.

Authors:  Larry J Dumont; James P AuBuchon
Journal:  Transfusion       Date:  2008-02-22       Impact factor: 3.157

3.  The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response.

Authors:  Katherine Radwanski; Olivier Garraud; Fabrice Cognasse; Hind Hamzeh-Cognasse; Jean-Marc Payrat; Kyungyoon Min
Journal:  Transfusion       Date:  2013-03-05       Impact factor: 3.157

4.  Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.

Authors:  Ross M Fasano; Garrett S Booth; Megan Miles; Liping Du; Tatsuki Koyama; Emily Riehm Meier; Naomi L C Luban
Journal:  Br J Haematol       Date:  2014-09-26       Impact factor: 6.998

5.  Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method.

Authors:  Louis Thibault; Annie Beauséjour; Marie Joëlle de Grandmont; Réal Lemieux; Jean-François Leblanc
Journal:  Transfusion       Date:  2006-08       Impact factor: 3.157

6.  Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies.

Authors:  Christopher A Tormey; Gary Stack
Journal:  Blood       Date:  2009-08-27       Impact factor: 22.113

7.  Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

Authors:  Jeanne E Hendrickson; Traci E Chadwick; John D Roback; Christopher D Hillyer; James C Zimring
Journal:  Blood       Date:  2007-06-25       Impact factor: 22.113

8.  WBC reduction of RBC transfusions is associated with a decreased incidence of RBC alloimmunization.

Authors:  Neil Blumberg; Joanna M Heal; Kelly F Gettings
Journal:  Transfusion       Date:  2003-07       Impact factor: 3.157

9.  A Genome-Wide Screen for Large-Effect Alloimmunization Susceptibility Loci among Red Blood Cell Transfusion Recipients with Sickle Cell Disease.

Authors:  Neil A Hanchard; Joann M Moulds; John W Belmont; Alice Chen
Journal:  Transfus Med Hemother       Date:  2014-11-07       Impact factor: 3.747

Review 10.  Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

Authors:  Alex B Ryder; James C Zimring; Jeanne E Hendrickson
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

View more
  14 in total

Review 1.  Shifting ground and gaps in transfusion support of patients with hematological malignancies.

Authors:  Christine Cserti-Gazdewich
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.

Authors:  Raisa Balbuena-Merle; Susanna A Curtis; Lesley Devine; David R Gibb; Matthew S Karafin; Chance John Luckey; Christopher A Tormey; Alexa J Siddon; John D Roberts; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-07-29       Impact factor: 3.157

Review 3.  Red Cell Transfusions in the Genomics Era.

Authors:  Jamal H Carter; Willy A Flegel
Journal:  Semin Hematol       Date:  2019-11-08       Impact factor: 3.851

4.  Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

Authors:  Sandhya R Panch; Bipin N Savani; David F Stroncek
Journal:  Semin Hematol       Date:  2019-10       Impact factor: 3.851

5.  Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates.

Authors:  Louis Thibault; Marie Joëlle de Grandmont; Marie-Pierre Cayer; Nathalie Dussault; Annie Jacques; Eric Ducas; Annie Beauséjour; André Lebrun
Journal:  Transfus Med Hemother       Date:  2019-06-27       Impact factor: 3.747

6.  Viable lymphocytes in fresh frozen plasma as a potential source of graft-versus-host disease: risks and solutions.

Authors:  Bruno Brando
Journal:  Blood Transfus       Date:  2021-07-29       Impact factor: 3.443

7.  Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.

Authors:  Marianne E M Yee; Cassandra D Josephson; Anne M Winkler; Jennifer Webb; Naomi L C Luban; Traci Leong; Sean R Stowell; Ross M Fasano
Journal:  Transfusion       Date:  2017-08-24       Impact factor: 3.337

Review 8.  Red Blood Cell Membrane Processing for Biomedical Applications.

Authors:  Luigia Rossi; Alessandra Fraternale; Marzia Bianchi; Mauro Magnani
Journal:  Front Physiol       Date:  2019-08-20       Impact factor: 4.566

9.  Comparison of two column agglutination tests for red blood cell antibody testing.

Authors:  Jonas Sawierucha; Marion Posset; Viola Hähnel; Christian L Johnson; James A Hutchinson; Norbert Ahrens
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

10.  Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate.

Authors:  Lívia Lara Pessoni; Marcos Antônio Ferreira; Julles Cristiane Rodrigues da Silva; Keila Correia de Alcântara
Journal:  Hematol Transfus Cell Ther       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.